← Leaderboards
Kristine Glunde
Johns Hopkins University
$12,806,818
Attributed
$16,317,236
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,317,236 · 11
By mechanism
R01$11,893,082 · 6
S10$1,981,375 · 2
P30$1,318,912 · 1
P50$742,169 · 1
R21$381,698 · 1
Top collaborators
- Ron Heeren6 shared
- Valina L. Dawson4 shared
- Tae-In Kam4 shared
- Chan-Hyun Na4 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Robert N Cole$2,029,196
- Ie-Ming Shih$14,895,140
- Georg Oeltzschner$2,708,626
- Richard Anthony Edward Edden$15,962,994
- Nicolaas Puts$657,885
Others in their field
Top investigators on “Image”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$332,241,999
- Leonard Freedman · Leidos Biomedical Research, Inc.$321,574,964
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$217,904,052
- Ethan Schreier · Associated Universities, Inc.$206,468,864
Research focus
ImageMolecularSignal TransductionTumorCancer CellNeoplasm MetastasisMalignant Breast NeoplasmResolutionMalignant NeoplasmsMammary NeoplasmsPathway InteractionsAffectIn VivoInnovationBiopsyBaseSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationDetectionTumor ProgressionCellsProteinsMolecular ImagingLymph NodesMetabolic
Grant awards (41)
Imaging Mass Spectrometry-Based Metabolomic Analysis of the Alzheimer's Brain$802,288
R01 · FY2025 · AG
Reprogramming of creatine metabolism in breast cancer metastasis$374,578
R01 · FY2025 · CA · contact PI
Mass Spectrometry Molecular Imaging and Multi-Omics$299,086
P30 · FY2025 · CA · contact PI
Imaging Mass Spectrometry-Based Metabolomic Analysis of the Alzheimer's Brain$818,662
R01 · FY2024 · AG
Reprogramming of creatine metabolism in breast cancer metastasis$355,850
R01 · FY2024 · CA · contact PI
Mass Spectrometry Molecular Imaging and Multi-Omics$339,942
P30 · FY2024 · CA · contact PI
Imaging Mass Spectrometry-Based Metabolomic Analysis of the Alzheimer's Brain$818,662
R01 · FY2023 · AG
Laser ablation-ICP-TOF mass spectrometer for advanced metallomic/elemental imaging of biomedical samples$689,750
S10 · FY2023 · OD · contact PI
Reprogramming of creatine metabolism in breast cancer metastasis$367,087
R01 · FY2023 · CA · contact PI
Mass Spectrometry Molecular Imaging and Multi-Omics$339,942
P30 · FY2023 · CA · contact PI
Imaging Mass Spectrometry-Based Metabolomic Analysis of the Alzheimer's Brain$818,662
R01 · FY2022 · AG
Reprogramming of creatine metabolism in breast cancer metastasis$374,578
R01 · FY2022 · CA · contact PI
Mass Spectrometry Molecular Imaging and Multi-Omics$339,942
P30 · FY2022 · CA · contact PI
timsTOF fleX with MALDI-2 for Advanced Mass Spectrometry Imaging$1,291,625
S10 · FY2021 · OD · contact PI
Molecular studies of the MR-detectable oncometabolite glycerophosphocholine$374,578
R01 · FY2021 · CA · contact PI
Hypoxia-derived molecular MSI signatures to predict breast cancer outcome$266,417
R01 · FY2021 · CA · contact PI
Hypoxia-derived molecular MSI signatures to predict breast cancer outcome$436,586
R01 · FY2020 · CA · contact PI
Molecular studies of the MR-detectable oncometabolite glycerophosphocholine$374,578
R01 · FY2020 · CA · contact PI
Hypoxia-derived molecular MSI signatures to predict breast cancer outcome$112,585
R01 · FY2020 · CA · contact PI
Hypoxia-derived molecular MSI signatures to predict breast cancer outcome$429,142
R01 · FY2019 · CA · contact PI
Molecular studies of the MR-detectable oncometabolite glycerophosphocholine$363,340
R01 · FY2019 · CA · contact PI
Hypoxia-derived molecular MSI signatures to predict breast cancer outcome$436,586
R01 · FY2018 · CA · contact PI
Molecular studies of the MR-detectable oncometabolite glycerophosphocholine$374,531
R01 · FY2018 · CA · contact PI
Hypoxia-derived molecular MSI signatures to predict breast cancer outcome$452,109
R01 · FY2017 · CA · contact PI
Molecular studies of the MR-detectable oncometabolite glycerophosphocholine$373,912
R01 · FY2017 · CA · contact PI
Multi-scale Molecular Imaging of the Degradome in Breast Tumors$340,300
R01 · FY2015 · CA · contact PI
Molecular Imaging of the Extracellular Matrix and its Avenues for Metastasis$182,368
P50 · FY2015 · CA · contact PI
Multi-scale Molecular Imaging of the Degradome in Breast Tumors$330,091
R01 · FY2014 · CA · contact PI
Molecular Imaging of the Extracellular Matrix and its Avenues for Metastasis$180,406
P50 · FY2014 · CA · contact PI
Multi-scale Molecular Imaging of the Degradome in Breast Tumors$319,882
R01 · FY2013 · CA · contact PI
Molecular Imaging of the Extracellular Matrix and its Avenues for Metastasis$192,120
P50 · FY2013 · CA · contact PI
Multi-scale Molecular Imaging of the Degradome in Breast Tumors$340,300
R01 · FY2012 · CA · contact PI
Imaging hypoxia-driven signaling pathways in the breast tumor microenvironment$294,857
R01 · FY2012 · CA · contact PI
Molecular Imaging of the Extracellular Matrix and its Avenues for Metastasis$187,275
P50 · FY2012 · CA · contact PI
Multi-scale Molecular Imaging of the Degradome in Breast Tumors$340,300
R01 · FY2011 · CA · contact PI
Imaging hypoxia-driven signaling pathways in the breast tumor microenvironment$292,896
R01 · FY2011 · CA · contact PI
Imaging hypoxia-driven signaling pathways in the breast tumor microenvironment$298,598
R01 · FY2010 · CA · contact PI
Imaging hypoxia-driven signaling pathways in the breast tumor microenvironment$294,335
R01 · FY2009 · CA · contact PI
Imaging hypoxia-driven signaling pathways in the breast tumor microenvironment$316,792
R01 · FY2008 · CA · contact PI
Imaging lysosomes to predict metastasis in breast cancer$171,589
R21 · FY2006 · CA · contact PI
Imaging lysosomes to predict metastasis in breast cancer$210,109
R21 · FY2005 · CA